Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins

Biochemical and Biophysical Research Communications

Volumn 451, Issue 2, 2014, Pages 208-214

  Wang, Sheng Fan ^a,b   Tseng, Sung Pin ^a   Yen, Chia Hung ^a   Yang, Jyh Yuan ^c   Tsao, Ching Han ^b   Shen, Chun Wei ^d   Chen, Kuan Hsuan ^a   Liu, Fu Tong ^b   Liu, Wu Tse ^f   Chen, Yi Ming Arthur ^a,e   Huang, Jason C ^f  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c CENTER FOR DISEASE CONTROL   (Taiwan)

^d KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Anti spike antibody; Antibody dependent enhancement; Fc receptors; HL CZ; SARS CoV

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; FC RECEPTOR; FC RECEPTOR II; INTERLEUKIN 4; INTERLEUKIN 6; MONOCLONAL ANTIBODY; NUCLEOCAPSID PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS SPIKE PROTEIN;

ANTIBODY DEPENDENT ENHANCEMENT; APOPTOSIS; ARTICLE; CELL DIVISION; CONCENTRATION (PARAMETERS); CYTOPATHOGENIC EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MONOCYTE MACROPHAGE PRECURSOR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS NEUTRALIZATION;

DENGUE VIRUS GROUP; FELIDAE; SARS CORONAVIRUS;

ANTI-SPIKE ANTIBODY; ANTIBODY-DEPENDENT ENHANCEMENT; FC RECEPTORS; HL-CZ; SARS-COV;

ANIMALS; ANTIBODIES, VIRAL; CELL LINE; CERCOPITHECUS AETHIOPS; CYTOPATHOGENIC EFFECT, VIRAL; HUMANS; NUCLEOCAPSID PROTEINS; PEPTIDYL-DIPEPTIDASE A; RECEPTORS, IGG; RECEPTORS, VIRUS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SPIKE GLYCOPROTEIN, CORONAVIRUS; VERO CELLS; VIRAL VACCINES; VIRUS REPLICATION;

EID: 84906940416     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.07.090     Document Type: Article

References (27)

1. P.R. Hsueh, and P.C. Yang SARS outbreak in Taiwan Emerg. Infect. Dis. 10 2004 1514 1515 (author reply 1515-1516)
2. M.S. Chang, Y.T. Lu, S.T. Ho, C.C. Wu, T.Y. Wei, C.J. Chen, Y.T. Hsu, P.C. Chu, C.H. Chen, J.M. Chu, Y.L. Jan, C.C. Hung, C.C. Fan, and Y.C. Yang Antibody detection of SARS-CoV spike and nucleocapsid protein Biochem. Biophys. Res. Commun. 314 2004 931 936
3. Y.M. Chen, S.Y. Liang, Y.P. Shih, C.Y. Chen, Y.M. Lee, L. Chang, S.Y. Jung, M.S. Ho, K.Y. Liang, H.Y. Chen, Y.J. Chan, and D.C. Chu Epidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003 J. Clin. Microbiol. 44 2006 359 365
4. W. Li, M.J. Moore, N. Vasilieva, J. Sui, S.K. Wong, M.A. Berne, M. Somasundaran, J.L. Sullivan, K. Luzuriaga, T.C. Greenough, H. Choe, and M. Farzan Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Nature 426 2003 450 454
5. S.W. Barnett, B. Burke, Y. Sun, E. Kan, H. Legg, Y. Lian, K. Bost, F. Zhou, A. Goodsell, J. Zur Megede, J. Polo, J. Donnelly, J. Ulmer, G.R. Otten, C.J. Miller, M. Vajdy, and I.K. Srivastava Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvant J. Virol. 84 2010 5975 5985
6. Z. Chen, D. Pei, L. Jiang, Y. Song, J. Wang, H. Wang, D. Zhou, J. Zhai, Z. Du, B. Li, M. Qiu, Y. Han, Z. Guo, and R. Yang Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein Clin. Chem. 50 2004 988 995
7. S.M. Tirado, and K.J. Yoon Antibody-dependent enhancement of virus infection and disease Viral Immunol. 16 2003 69 86
8. C.W. Olsen, W.V. Corapi, C.K. Ngichabe, J.D. Baines, and F.W. Scott Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages J. Virol. 66 1992 956 965
9. W.T. Liu, C.L. Chen, S.S. Lee, C.C. Chan, F.L. Lo, and Y.C. Ko Isolation of dengue virus with a human promonocyte cell line Am. J. Trop. Med. Hyg. 44 1991 494 499
10. P.R. Hsueh, C.H. Hsiao, S.H. Yeh, W.K. Wang, P.J. Chen, J.T. Wang, S.C. Chang, C.L. Kao, and P.C. Yang Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan Emerg. Infect. Dis. 9 2003 1163 1167
11. Y.P. Shih, C.Y. Chen, S.J. Liu, K.H. Chen, Y.M. Lee, Y.C. Chao, and Y.M. Chen Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus J. Virol. 80 2006 10315 10324
12. S.S. Jiang, T.C. Chen, J.Y. Yang, C.A. Hsiung, I.J. Su, Y.L. Liu, P.C. Chen, and J.L. Juang Sensitive and quantitative detection of severe acute respiratory syndrome coronavirus infection by real-time nested polymerase chain reaction Clin. Infect. Dis. 38 2004 293 296
13. S.F. Wang, J.C. Huang, Y.M. Lee, S.J. Liu, Y.J. Chan, Y.P. Chau, P. Chong, and Y.M. Chen DC-SIGN mediates avian H5N1 influenza virus infection in cis and in trans Biochem. Biophys. Res. Commun. 373 2008 561 566
14. S.F. Wang, K.H. Chen, A. Thitithanyanont, L. Yao, Y.M. Lee, Y.J. Chan, S.J. Liu, P. Chong, W.T. Liu, J.C. Huang, and Y.M. Chen Generating and characterizing monoclonal and polyclonal antibodies against avian H5N1 hemagglutinin protein Biochem. Biophys. Res. Commun. 382 2009 691 696
15. A. Du, T. Daidoji, T. Koma, M.S. Ibrahim, S. Nakamura, U.C. de Silva, M. Ueda, C.S. Yang, T. Yasunaga, K. Ikuta, and T. Nakaya Detection of circulating Asian H5N1 viruses by a newly established monoclonal antibody Biochem. Biophys. Res. Commun. 378 2009 197 202
16. M. Jaume, M.S. Yip, Y.W. Kam, C.Y. Cheung, F. Kien, A. Roberts, P.H. Li, I. Dutry, N. Escriou, M. Daeron, R. Bruzzone, K. Subbarao, J.S. Peiris, B. Nal, and R. Altmeyer SARS CoV subunit vaccine: Antibody-mediated neutralisation and enhancement Hong Kong Med. J. 18 Suppl 2 2012 31 36
17. M. Jaume, M.S. Yip, C.Y. Cheung, H.L. Leung, P.H. Li, F. Kien, I. Dutry, B. Callendret, N. Escriou, R. Altmeyer, B. Nal, M. Daeron, R. Bruzzone, and J.S. Peiris Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcgammaR pathway J. Virol. 85 2011 10582 10597
18. I. Hamming, W. Timens, M.L. Bulthuis, A.T. Lely, G. Navis, and H. van Goor Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis J. Pathol. 203 2004 631 637
19. M. Yilla, B.H. Harcourt, C.J. Hickman, M. McGrew, A. Tamin, C.S. Goldsmith, W.J. Bellini, and L.J. Anderson SARS-coronavirus replication in human peripheral monocytes/macrophages Virus Res. 107 2005 93 101
20. W. Wang, L. Ye, B. Li, B. Gao, Y. Zeng, L. Kong, X. Fang, H. Zheng, Z. Wu, and Y. She Up-regulation of IL-6 and TNF-alpha induced by SARS-coronavirus spike protein in murine macrophages via NF-kappaB pathway Virus Res. 128 2007 1 8
21. T. Yoshikawa, T. Hill, K. Li, C.J. Peters, and C.T. Tseng Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells J. Virol. 83 2009 3039 3048
22. S. Park, K. Sestak, D.C. Hodgins, D.I. Shoup, L.A. Ward, D.J. Jackwood, and L.J. Saif Immune response of sows vaccinated with attenuated transmissible gastroenteritis virus (TGEV) and recombinant TGEV spike protein vaccines and protection of their suckling pigs against virulent TGEV challenge exposure Am. J. Vet. Res. 59 1998 1002 1008
23. S.W. Gollins, and J.S. Porterfield Flavivirus infection enhancement in macrophages: Radioactive and biological studies on the effect of antibody on viral fate J. Gen. Virol. 65 Pt 8 1984 1261 1272
24. W.E. Robinson Jr., D.C. Montefiori, D.H. Gillespie, and W.M. Mitchell Complement-mediated, antibody-dependent enhancement of HIV-1 infection in vitro is characterized by increased protein and RNA syntheses and infectious virus release J. Acquir. Immune Defic. Syndr. 2 1989 33 42
25. C. Olsen, and F. Scott Evaluation of antibody-dependent enhancement of feline infectious peritonitis virus infectivity using in situ hybridization Microb. Pathog. 14 1993 275 285
26. M. Zhu SARS immunity and vaccination Cell. Mol. Immunol. 1 2004 193 198
27. Y.W. Kam, F. Kien, A. Roberts, Y.C. Cheung, E.W. Lamirande, L. Vogel, S.L. Chu, J. Tse, J. Guarner, S.R. Zaki, K. Subbarao, M. Peiris, B. Nal, and R. Altmeyer Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro Vaccine 25 2007 729 740